When the phenotype is complex and the number of candidate variants is overwhelming, finding the variants that matter can become a major interpretation bottleneck. Franklin by QIAGEN helps labs accelerate and standardize NGS interpretation for rare disease analysis, turning millions of variants into a concise list of clinically relevant findings. By bringing together AI-assisted variant prioritization, phenotype-driven analysis, automated ACMG classification and evidence from 100+ integrated databases, Franklin gives your team one comprehensive environment to rapidly narrow searches and support more efficient, consistent rare disease interpretation across large panels and whole exome sequencing.